(Q39150423)

9 September 2017

title

Targeting NK-cell checkpoints for cancer immunotherapy (English)

1 reference

9 September 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Pedro Berraondo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mariona Cabo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Miguel López-Botet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ignacio Melero, MD-PhD

8

object named as

Ignacio Melero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1

Aura Muntasell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Luna Cordeiro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ascension López-Díaz de Cerio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

22 February 2017

1 reference

Current Opinion in Immunology

9 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

73-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer

13 June 2020

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI61226

Targeting CD137 enhances the efficacy of cetuximab.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI73014

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2010-08-301945

Identifiers

DOI

10.1016/J.COI.2017.01.003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28236750%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference